The Clinical Utility of Genetic Markers in NSCLC
Description: Arturo Anguiano, MD discusses the epidemiology of non-small cell lung cancer (NSCLC) and established as well as emerging biomarkers that can guide clinical decision-making related to the use of approved and investigational targeted therapies for these patients.
Learning objectives — at the conclusion of this program participants will be able to:
• Discuss NSCLC in a medical context and communicate current disease epidemiology and key statistics
• Describe the use of established genetic markers for selecting targeted NSCLC therapies
• Identify emerging genetic markers relevant to the treatment of NSCLC